Cresco Labs (CRLBF) Non Operating Income (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Non Operating Income came in at -$14.0 million in Q1 2026, up 3.72% YoY from -$13.5 million in Q1 2025, and down 20.41% on a QoQ basis from -$11.6 million in Q4 2025.
Cresco Labs (CRLBF) Non Operating Income (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Non Operating Income data on file, last reported at -$14.0 million in Q1 2026.
- Quarterly Non Operating Income rose 3.72% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.9 million (up 43.88% YoY) and the FY2025 annual result came in at -$67.4 million, up 42.81% from the prior year.
- Non Operating Income declined to -$14.0 million in Q1 2026, from -$11.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$757000.0 in Q3 2022 to a low of -$73.3 million in Q2 2024.
- A 5-year average of -$17.7 million and a median of -$14.3 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 91.95% — and 2023, when it tumbled 1410.57%.
- Tracing CRLBF's Non Operating Income over 5 years: stood at -$13.4 million in 2022, then dropped by 6.71% to -$14.3 million in 2023, then slipped by 14.49% to -$16.4 million in 2024, then rose by 29.06% to -$11.6 million in 2025, then fell by 20.41% to -$14.0 million in 2026.
- The last three Non Operating Income figures came in at -$14.0 million (Q1 2026), -$11.6 million (Q4 2025), and -$27.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Cresco Labs | 291.27 Mn | 227.16 Mn | 86.95 Mn | -16.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.97 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Sep 30, 2025 | -27.93 Mn |
| Jun 30, 2025 | -13.40 Mn |
| Mar 31, 2025 | -14.51 Mn |
| Dec 31, 2024 | -16.35 Mn |
| Sep 30, 2024 | -15.02 Mn |
| Jun 30, 2024 | -73.32 Mn |
| Mar 31, 2024 | -13.22 Mn |
| Dec 31, 2023 | -14.28 Mn |
| Sep 30, 2023 | -11.44 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Mar 31, 2023 | -14.59 Mn |
| Dec 31, 2022 | -13.38 Mn |
| Sep 30, 2022 | -757,000.00 |
| Jun 30, 2022 | -7.34 Mn |
| Mar 31, 2022 | -21.14 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -9.41 Mn |
| Jun 30, 2021 | 1.24 Mn |